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Background: Cytotoxic T cells (CTL) play a central role in the control of viral infections. Their antiviral activity can
be mediated by at least two cytotoxic pathways, namely the granule exocytosis pathway, involving perforin and
granzymes, and the Fas-FasL pathway. It was shown that the level of Friend retrovirus (FV) replication determines
the cytotoxic pathway for the control of viral infection. In low-level infection only the Fas pathway is active,
whereas cytotoxic molecules are not produced. In the current study, we elucidate the role of CD4+ regulatory
T cells (Tregs) in suppressing the exocytosis pathway during an asymptomatic low-level infection.
Findings: We show that even a low-level retrovirus infection induced a strong activation and proliferation of
natural Tregs. The expanded Tregs suppressed the proliferation of virus-specific CD8+ T cells and the production of
cytotoxic molecules by these cells. Not surprisingly, the in vivo killing activity of these CD8+ T cells was rather weak.
Selective depletion of Foxp3+ Tregs resulted in de novo granzyme production and augmented virus-specific in vivo
killing, but did not affect the low-level virus replication.
Conclusions: Expanded natural Tregs determined the cytotoxic pathways of virus-specific effector CD8+ T cells during
the acute phase of retroviral infection.
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CD8+ cytotoxic T cells (CTL) can eliminate target cells
by at least two independent cytolytic pathways, the gran-
ule exocytosis pathway and the Fas-FasL pathway [1].
Previously, we compared the CTL response against low-
and high-level Friend retrovirus (FV) infection of mice
[2]. Low-level infection induced moderate activation of
CD8+ T cells expressing only FasL, whereas high-level
infection resulted in extensive expansion of CD8+ effector
T cells secreting molecules of the exocytosis pathway. In
an in vitro model of HBV infection [3] it was also de-
scribed that virus antigen levels were critical for regulating
the quality of antigen-specific CD8+ T cells. It was con-
cluded that stronger antigen stimulation is needed for the
production of granzymes compared to FasL [4]. Along
these lines, a certain density of antigen presented on DC* Correspondence: gennadiy.zelinskyy@uni-due.de
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reproduction in any medium, provided the orwas necessary for the differentiation of cytotoxic CD8+ T
cells [5]. These publications acknowledge the significance
of antigen levels for CD8+ T cell cytotoxicity, whereas the
mechanisms that suppress the production of cytotoxic
molecules in low-level virus infections were unknown. In
addition, most of our basic concepts on the regulation of
acute anti-viral immune responses are derived from model
infections with high viral loads (e.g. LCMV), whereas the
immune responses to low-level asymptomatic infections
are poorly defined. A more detailed understanding of such
infection courses is very important especially in chronic
viral infections as acute viral loads have been shown to
correlate significantly with chronic viral set points and on-
set of chronic disease in infections like HCV or HIV [6,7].
In HCV infected patients, an acute low-level asymptom-
atic infection even results significantly more often in
chronicity and thus is a negative prognostic factor [7].
In our previous studies we showed that during high-
level FV infection the population of Foxp3+ regulatory
T cells (Tregs) follows the expansion of effector CD8+ Tal Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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during the late phase of acute [9,10] and during chronic
infection [11]. Studies on other viral infections also
showed that Tregs were involved in the suppression of
effector T cell functions [12-15]. Similarly, low-level
F-MuLV infection induced the expansion of virus-
specific CD8+ T cells that recognized the F-MuLV gly-
cosylated gag epitope (Figure 1A). Also CD4+ T cells
recognizing the FV-H19-Env F-MuLV epitope [16] ex-
panded (Figure 1B). The expansion of virus-specific CD8+
and CD4+ T cells was detectable at as early as day 8 after
infection with F-MuLV and peaked on day 10. Prior to day
8 post infection no effector T cell expansion was detected
(data not shown). We wanted to determine whether Tregs
also expand during low-level virus infections and if theyFigure 1 Expansion of Treg after infection with F-MuLV. C57BL/6 mice
Then, suspensions of spleen cells were prepared. Flow cytometry was used
restricted F-MuLV glycosylated gag epitope (MHC I Tetramer+), and CD4+ T
Tetramer+) in the spleen. A. Numbers of CD8+ MHC I Tetramer+ T cells per
per one million spleen cells. C. Numbers of CD4+ Foxp3+ T cells per one m
per one million spleen cells. E. A representative dot plot shows the gating-
graph, numbers of CD4+Foxp3+Npn-1+ cells per one million nucleated cell
nucleated cells. F. A representative dot plot shows the expression of Helios
gated CD4+Foxp3+Npn-1−iTregs (lower panel). The numbers in the upper q
from three independent experiments with similar results. Differences betwe
analyzed by an unpaired t-test. Statistically significant differences betweeninfluence the pathway of CD8+ T cell cytotoxicity. To
investigate the role of Tregs in C57BL/6 mice with low-
level retrovirus infection we performed flow cytometric
analysis of CD4+ Foxp3+ T cells [9] during the acute
phase of F-MuLV infection [2]. Virus infection was as-
sociated with a moderate but significant enhancement
of Treg numbers in the spleen at days 8 and 10 post in-
fection (dpi). At 8 dpi the mean frequency of Tregs was
increased by 1.7 fold (Figure 1C). The data document
the expansion of Tregs after low-level F-MuLV infection
concomitant with the peak CD8+ and CD4+ T cell re-
sponse (Figure 1A, B, and C). This finding was surprising
as in the case of high-level FV infection the expansion
of Tregs was detectable only two days later [9]. By using
the proliferation marker Ki-67 [17], we analyzed nextwere infected with F-MuLV and sacrificed 8 or 10 days after infection.
to quantify the numbers of CD8+ T cells specific for the H-2Db-
cells specific for the Ab-restricted FV-H19-Env epitope (MHC II
one million spleen cells. B. Numbers of CD4+ MHC II Tetramer+ T cells
illion spleen cells. D. Numbers of CD4+Foxp3+ T cells expressing Ki-67
strategy to identify CD4+ Foxp3+ that were Npn-1+ or Npn-1−. Upper
s. Lower panel, numbers of CD4+Foxp3+Npn-1−cells per one million
and Ki67 on gated CD4+Foxp3+Npn-1+ nTregs (upper panel) and on
uadrants represent the percentages of Helios+ cells. Data was pooled
en naïve mice and mice infected for 10 days with F-MuLV were
the groups are indicated in the figure.
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proliferation of CD4+Foxp3+ cells. In accordance with
the expansion of Tregs, significantly more CD4+Foxp3+
cells expressed Ki-67 at 8 and 10 dpi in comparison to
non-infected mice (Figure 1D). Foxp3+ Tregs can be
divided into thymic-derived “natural” Tregs (nTregs) and
Foxp3- conventional T helper cells that, in peripheral tis-
sues, convert into Foxp3+ Tregs, so called induced TregsFigure 2 CD8+ T cell responses in F-MuLV infected Treg-depleted DE
toxin (DT) to deplete Foxp3+ Tregs during the first 10 days of infection (wh
DT (black columns). Flow cytometry was used to determine numbers of CD
CD43+CD8+ T cells expressing granzyme A (GzmA) or granzyme B (GzmB) (
nucleated cells for a group of 5-7 mice. Data was pooled from two indepe
were analyzed by an unpaired t-test. Statistically significant differences betw
mice were loaded with FV-DbGagL peptides and labelled with CFSE to perfor
without FV peptide were used from CD45.1 B6 mice. Target cells were inje
10 days or F-MuLV-infected DEREG mice treated with DT. A histogram of
(peptide loaded) from the spleen of representative mice for each group (
percentage of target cell killing in the spleen. D. Flow cytometry was used to
(Eomes) in CD8+ T cells from naïve mice and CD8+ T cells reactive with FV-Db
between the groups were analyzed by an unpaired t-test. Statistically significa(iTregs) [18]. We therefore analyzed whether F-MuLV
infection resulted in expansion of nTregs or iTregs by
using the transmembrane glycoprotein neuropilin-1 (Npn-1)
as a marker for nTregs [19,20]. A significantly enhanced
frequency of CD4+Foxp3+Npn-1+ (nTreg) was observed at
8 and 10 dpi compared to non-infected mice (Figure 1E
upper panel). In contrast, after F-MuLV infection (Figure 1E
lower panel), the frequency of CD4+Foxp3+Npn-1−(iTreg)REG mice. F-MuLV-infected DEREG mice were treated with diphtheria
ite columns). Control mice were infected but received PBS instead of
8+ T cells reactive with FV-DbgagL class I tetramers (A), or numbers of
B). Each column represents mean numbers plus SEM per one million
ndent experiments with similar results. Differences between the groups
een the groups are indicated in the figure. C. Splenocytes from naïve
m an in vivo CTL assay. As negative control, equal numbers of cells
cted intravenously into naïve DEREG mice, DEREG mice infected for
CD45.1+ CFSE- (transferred cells without peptide) and CFSE+ cells
one from a group of 5 animals) is presented. The figure shows the
determine the mean fluorescence intensity (MFI) of Eomesodermin
gagL class I tetramers from 10 days F-MuLV infected mice. Differences
nt differences between the groups are indicated in the figure.
Figure 3 F-MuLV load in DEREG mice infected with F-MuLV and
depleted for Tregs. F-MuLV-infected DEREG mice were treated with
DT to deplete Foxp3+ Treg during the first 10 days of infection
(white columns). Control DEREG mice were infected but received
PBS instead of DT (black columns). Viral loads were measured in the
spleen of the 10 days infected mice. Each column represents mean
numbers plus SEM per one million nucleated cells. Data was
pooled from two independent experiments with similar results.
Differences between the groups were analyzed by an unpaired
t-test. A statistically significant difference between the groups was
not found (P = 0.19).
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shown that activated Tregs with enhanced suppressive
activity express a member of the Ikaros transcription
regulating family, called Helios [21,22]. We analyzed the
expression of Helios in combination with the prolifera-
tion marker Ki-67 on populations of nTregs (Npn-1+)
(Figure 1F upper panel) and iTregs (Npn-1−) (Figure 1F
lower panel). The percentage of activated Helios + cells
in the population of nTregs was higher in infected than
in naïve mice (83 % to 69 % respectively) (Figure 1F,
upper panel), whereas the activation level in the
population of iTregs was unchanged after infection
with F-MuLV (Figure 1F, lower panel). The combination
of activation and proliferation markers allowed us to show
that low-level retrovirus infection selectively induced pro-
liferation and activation of nTregs.
To determine the influence of activated nTregs on the
population of virus-specific CD8+ effector T in vivo we
used the DEREG mouse model [23]. Injection of diph-
theria toxin (DT) into DEREG mice, which express the
GFP and DT receptor under the control of the Foxp3
promoter, depleted more than 95% of the GFP+ Tregs in
lymphatic organs (data not shown [9,23,24]). Only Tregs
but no other cell population was affected by this treat-
ment [24]. During acute F-MuLV infection, activation
and expansion of FV-specific CD8+ T cells was observed
(Figure 2A, [2]). Depletion of Tregs resulted in a highly
significant expansion of virus-specific CD8+ T cells
(Figure 2A), with a 5-times higher mean frequency of
tetramer+CD8+ T cells recognizing the H-2Db-restricted
F-MuLV glycosylated gag epitope. However, the most
important question was whether or not nTregs would
also influence the pathway of CD8+ T cell cytotoxicity.
We therefore compared the production of the cytotoxic
molecules granzyme A and granzyme B in infected mice
depleted for Tregs with that of non-depleted mice [9].
As described previously [2], low-level F-MuLV infection
did not induce any expression of granzymes in CD8+ T
cells (Figure 2B). However, after depletion of Tregs,
the CD43+ effector CD8+ T cells started to produce
the cytotoxic molecules granzyme A and B. After DT
treatment a mean of about 5,000 CD8+ T cells per one
million nucleated spleen cells produced granzyme A
and a mean of about 4,500 CD8+ T cells granzyme B
(Figure 2B). To analyze if induction of granzyme pro-
duction correlated with enhanced CD8+ T cell cytotoxicity
we performed an in vivo CTL assay [9]. We compared the
elimination of CFSE-labeled spleen cells loaded with the
FV-DbGagL epitope peptide in F-MuLV infected versus
F-MuLV infected and DT treated DEREG mice. In
F-MuLV infected mice, moderate killing that reached
only up to 12% of the target cells was found (Figure 2C).
In contrast, CD8+ T cells that expanded in the absence
of Tregs were highly cytotoxic and eliminated about70% of the peptide loaded target cells. These findings
correlate with our results on the different cytotoxic
pathways that are utilized for killing target cells in these
two different groups of mice. Whereas only low-level
killing by the Fas-FasL pathway was induced by F-MuLV
infection [2], more efficient killing by cytotoxic molecules
was observed in infected, Treg-depleted mice (Figure 2C).
The production of cytotoxic molecules was described to
be regulated by the transcription factor Eomesodemin
(Eomes) [25]. We therefore compared the expression
of Eomes in CD8+ T cells from naïve mice versus
virus-specific CD8+ T cells from F-MuLV infected mice
(Figure 2D). Interestingly, Eomes was highly expressed in
tetramer+CD8+ T cells from infected mice but not detect-
able in CD8+ T cells from naïve mice. The data suggest
that the block of production of granzymes by nTregs
during low-level infection occurred after the expression
of the transcription factor Eomes. This was supported
by the finding that Treg depletion did not influence
expression levels of Eomes in virus-specific CD8+ T
cells (data not shown).
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hanced functional activation of virus-specific cytotoxic
CD8+ T cells after Treg depletion results in improved
elimination of virus-infected target cells. However, in
case of the low-level infection with F-MuLV, which is
already well controlled by FasL expressing CD8+ T cells
[2], the induction of the exocytosis pathway after deple-
tion of Tregs did not result in reduced viral loads
compared to infected non-depleted mice (Figure 3).
This result indicates that even the limited activation of
CD8+ T cells by F-MuLV was sufficient for controlling
low-level virus replication. In low-level infections, virus-
infected cells are rare and it does not seem to be an
advantage for the host to have large numbers of highly
activated T cells to control virus spread. Instead, the
induction of CD8+ T cells that produce cytotoxic mol-
ecules might enhance the risk of immunopathology dur-
ing an acute infection. The risk of immunopathology may
only be justified if a fast replicating pathogen has to be
kept in check, but not during a low-level virus infection.
In the later scenario, only moderate CD8+ T cell activation
with no induction of the potentially dangerous exocytosis
pathway is sufficient for virus control. Furthermore, our
current data indicate that virus-driven activation and
expansion of nTregs is a key factor in down-regulating
CD8+ T cell activation levels and cytotoxic pathways in
low-level infections. Thus, in the case of low-level virus
infection, specific CD8+ T cells may be functionally sup-
pressed by Tregs, which may result in incomplete elim-
ination of the virus and establishment of chronicity.
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